Patent details
EP2325171 Title: Quinoline derivatives for treating retinal diseases
Basic Information
- Publication number:
- EP2325171
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP111552253
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Quinoline derivatives for treating retinal diseases
- French Title of Invention:
- Dérivés de quinoline pour le traitement des maladies rétiniennes
- German Title of Invention:
- Chinolinderivate zur Behandlung retinaler Erkrankungen
- SPC Number:
Dates
- Filing date:
- 26/05/2006
- Grant date:
- 09/10/2013
- EP Publication Date:
- 09/10/2013
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/05/2011
- EP B1 Publication Date:
- 09/10/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/05/2014
- Expiration date:
- 26/05/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/05/2006
- Name:
- Aldexa Therapeutics Inc.
- Address:
- 15 New England Executive Park, Burlington, MA 01803, United States (US)
Inventor
1
- Name:
- Dowling John E.
- Address:
- United States (US)
2
- Name:
- Chabala John C.
- Address:
- United States (US)
3
- Name:
- Jordan Thomas A
- Address:
- United States (US)
Priority
1
- Priority Number:
- 685460 P
- Priority Date:
- 26/05/2005
- Priority Country:
- United States (US)
2
- Priority Number:
- 723577 P
- Priority Date:
- 04/10/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07D 215/38;
| Filing date | Document type | Number of pages |
|---|